NVDA+0.84%AAPL−2.51%GOOGL−1.17%MSFT−2.04%AMZN−0.15%TSM+2.85%SPCX−1.20%AVGO+0.21%
StockVS

NYSE · Medical Distribution · USD

McKesson Corporation (MCK) Stock Analysis

McKesson Corporation (MCK) is a Medical Distribution stock listed on NYSE and quoted in US Dollar.

MCK

$907.99

−$13.39 (−1.45%)

Sep 4, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare MCK with… →

MCK Key Statistics

As of Sep 4, 2026
Trading
Open
$911.15
Previous Close
$921.38
Day's Range
905.10–921.09
52-Week Range
683.38–999.00
Volume
879.20K
BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
0.31
Valuation
Market Cap
$105.86B
P/E Ratio
24.69
Forward P/EShare price divided by forecast earnings for the year ahead, rather than the year just past.
17.99
PEG RatioThe P/E ratio divided by the expected earnings growth rate. It puts a high P/E in the context of how fast profits are growing.
1.72
P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
0.26
EPS (ttm)Profit attributable to each share over the last twelve months.
36.77
Financials (FY)
Revenue (FY)
$403.43B+12.36%
Net Income (FY)
$4.76B+44.52%
Profit marginThe share of revenue left as profit after all costs and taxes.
1.12%
Shares OutstandingThe total number of shares held by all investors. Market value is this figure multiplied by the share price.
116.59M
1-Year Return
+31.69%
Dividend and dates
Dividend
$3.76+0.41%
Ex-Dividend Date
September 1, 2026
Earnings Date
November 4, 2026estimated
Avg Volume
1.03M

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

MCK Stock Return by Calendar Year

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)+10.91%
2025+44.54%
2024+23.67%
2023+24.13%
2022+51.82%
2021+44.23%
2020+27.06%
2019+26.72%
2018−28.40%
2017+11.95%
2016 (partial year)−27.76%

As of September 4, 2026.

MCK Revenue and Earnings by Fiscal Year

FY ends March
Fiscal yearRevenueNet incomeNet margin
2025$403.43B$4.76B1.2%
2024$359.05B$3.30B0.9%
2023$308.95B$3.00B1.0%
2022$276.71B$3.56B1.3%
Fiscal yearRevenueGross profitOperating incomeNet incomeNet margin
2025$403.43B$14.55B$6.45B$4.76B1.2%
2024$359.05B$13.32B$4.82B$3.30B0.9%
2023$308.95B$12.83B$4.17B$3.00B1.0%
2022$276.71B$12.36B$4.58B$3.56B1.3%

Annual figures as reported, in the company's reporting currency. As of March 31, 2026.

MCK Dividend History

$3.06+15.0% vs 2024

Dividends per share, 2025 · 4 payments

YearDividends per sharePaymentsChange
2026*$2.583—
2025$3.064+15.0%
2024$2.664+14.7%
2023$2.324+14.9%
YearDividends per sharePaymentsChange
2026 (partial year)$2.583—
2025$3.064+15.0%
2024$2.664+14.7%
2023$2.324+14.9%
2022$2.024+13.5%
2021$1.784+7.2%
2020$1.664+3.7%
2019$1.604+9.6%
2018$1.464+17.7%
2017$1.244+342.9%
2016$0.281—

Most recent payment: $0.86 per share, ex-dividend September 1, 2026. Per-share amounts summed by calendar year from ex-dividend dates. Partial years are shown muted and marked with an asterisk.

MCK Valuation vs Medical Distribution Median

Median of 13 stocks
MetricMCKMedical Distribution medianvs median
P/E24.6925.784% below
P/S ratio0.260.3629% below
Profit margin1.12%−4.03%5.1 pts above

Medians across 13 Medical Distribution stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of September 4, 2026.

Recent News

All 20 articles ↓

News provided by third-party sources. Not financial advice.

Analysis

Data-derived

Company Overview

The market values McKesson Corporation (MCK) at $105.86B. It is classified in the Medical Distribution industry, within the Healthcare sector. The company reports 41,600 employees.

MCK last closed at $907.99 on September 4, 2026. That is −$13.39 (−1.45%) against the previous close. Over the past 52 weeks the price has ranged from $683.38 to $999.00. The latest close sits 32.87% above that 52-week low.

Financial Health

Fiscal 2025 revenue came to $403.43B. Against the prior fiscal year total of $359.05B, that is a change of +12.36%. Net income for the same year was $4.76B. That is +44.52% against the prior fiscal year. The reported profit margin is 1.12%. That is 5.1 percentage points above the Medical Distribution median of −4.03%. Trailing earnings per share are 36.77.

Across the 4 fiscal years on file, revenue moves from $276.71B in 2022 to $403.43B in 2025. Of those 4 years, 4 report positive net income.

Valuation Assessment

The trailing P/E ratio stands at 24.69. That is 4.23% below the Medical Distribution median of 25.78. The forward P/E on file is 17.99. The PEG ratio, which sets the P/E against expected earnings growth, reads 1.72. Measured against sales, the shares trade at 0.26 times revenue. On price-to-sales that is 28.69% below the Medical Distribution median of 0.36. The medians here are taken across 13 Medical Distribution companies that report the metric.

Over the trailing twelve months the price has returned +31.69%. Measured over 10 years, that is +18.26% a year compounded. Beta against the wider market is reported at 0.31. Daily returns over the trailing 10 years annualize to a volatility of 29.1%.

Growth & Income

Shareholders receive a dividend, yielding 0.41% on the latest price. That is 0.3 percentage points below the Medical Distribution median yield of 0.71%. The indicated annual rate is $3.76 a share. The ex-dividend date on file is September 1, 2026. Dividends are recorded for 11 calendar years; 2026 shows 3 payments totalling $2.58 a share. The year before, 2025, totalled $3.06 a share.

So far in 2026 the price is +10.91%. Across the complete calendar years on file, 2022 returned +51.82% and 2018 returned −28.40%. Of the 9 complete calendar years on file, 8 finished higher.

Peer Comparison

McKesson Corporation (MCK) operates in the Medical Distribution industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
McKesson Corporation MCK $105.86B 24.7
Cencora, Inc. COR $63.15B 25.1
Cardinal Health, Inc. CAH $57.49B 34.4
Henry Schein, Inc. HSIC $10.01B 26.5

The Medical Distribution industry average P/E ratio is 25.8x. McKesson Corporation trades at a P/E of 24.7.

Every figure above is read from this page's own data on each nightly rebuild. Informational only, not financial advice. As of September 4, 2026.

Related Medical Distribution Stocks

COR

Cencora, Inc.

$63.15B

 CAH

Cardinal Health, Inc.

$57.49B

 HSIC

Henry Schein, Inc.

$10.01B

 AHG

Akso Health Group

$726.49M

 FOCL

EDAP TMS S.A.

$190.70M

 QIPT

Quipt Home Medical Corp

$162.30M
View all Medical Distribution stocks →

Popular Healthcare Stocks

LLY

Eli Lilly and Company

$1.02T

 JNJ

Johnson & Johnson

$663.28B

 ABBV

AbbVie Inc.

$453.19B

 MRK

Merck & Co., Inc.

$370.89B

 UNH

UnitedHealth Group Incorporated

$356.47B
View all Healthcare stocks →

About McKesson Corporation

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: North American Pharmaceutical, Oncology & Multispecialty, Prescription Technology Solutions, and Medical-Surgical Solutions. The company distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products; delivers products to retail pharmacies, hospitals, long-term care centers, clinics, and institutions; and provides logistics and distribution services for manufacturers. It also provides consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies; gene therapy with InspiroGene, practice consulting, and vaccine distribution services; and technology solutions, as well as research, insights, technologies, and services to improve cancer and specialty care. In addition, the company helps in solving medication access, affordability, and adherence challenges for patients by working across healthcare to connect patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies. Further, it offers technology services, which includes electronic prior authorization, prescription price transparency, benefit insight, dispensing support services, patient enrollment, third-party logistics, and wholesale distribution support; medical-surgical supplies, laboratory equipment, pharmaceutical distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, and hospital reference labs, nursing homes, hospice and home health care agencies, government facilities ,and online marketplaces and retailers. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.

Visit website →